Navigation Links
Cancer Care of Western New York Becomes First Center in Western New York to Treat Cancer with RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
Date:11/6/2008

Fast form of precise radiotherapy targets tumors quickly and accurately

while minimizing exposure of surrounding healthy tissue

PALO ALTO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- During his annual physical check-up in March, David Kelver's doctor noticed he'd never had his tonsils out, and remarked that the right one looked a bit swollen. The doctor concluded, however, that the problem was minor and would clear up on its own, and sent him home. Several months later, Kelver, a 58-year-old engineer, noticed a lump in his neck. It turned out to be cancer that had started in his tonsil and spread to his lymph nodes.

That was the bad news. Some good news followed, however. Kelver found his way to Dhiren Shah, M.D., radiation oncologist at Cancer Care of Western New York, the first and only treatment center in the area to offer patients treatment using RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE: VAR). RapidArc, a new weapon in the fight against cancer, is a highly-precise form of radiotherapy that targets tumors quickly and accurately while minimizing exposure of surrounding healthy tissue.

"David had to choose between radical surgery or chemotherapy with radiation," said Dr. Shah. "He chose the chemo/radiation combination because it offers the same potential cure rate as surgery while being less invasive and disfiguring."

RapidArc technology makes it possible for Dr. Shah to deliver a precise image-guided IMRT treatment in two minutes or less, which is two to eight times faster than was previously possible with conventional IMRT. "The treatment itself is only about 40-60 seconds; the set-up prior to treatment takes longer," Kelver said. "I never had conventional radiation but I
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents
2. Bradmer sponsors physician panel to raise awareness of brain cancer treatments
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
4. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
5. Data Presented at Cancer Molecular Markers Meeting Suggests Clinical Benefit for Integrating New Molecular Tests
6. Breast Cancer Patients Take DNA Test to Determine Best Treatment
7. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
8. Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
9. Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer
10. AstraZeneca and M. D. Anderson Renew Cancer Research Collaboration
11. Japanese Cancer Association and Debiopharm Honour Japanese Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... blue dye test alternative is helping bring compl...step closer for pharma-companies. It is a non-dest...ped by Sepha for use with blister packs and it h...bal pharma-companies such as Sanofi-Avenis and Zyd...tivity improvements on the packaging line. Blist...
(Date:11/25/2009)... Speak at Economic Club of Canada , ...09 -- Ambassador to Speak at Economic Club of Cana...for International Investment, and Chairman and CEO...hy of David Appia go to www.investinfrance.org . ... with press to discuss recent pro-business initiat...
(Date:11/25/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, Brazil Bioethanol Market Analysis and ...com/p0165503/Brazil-Bioethanol-Market-Analysis-and...arket Analysis and Forecasts to 2013 ,, Summar... forecasts of the global bioethanol market and the...
(Date:11/24/2009)... also Visit Detroit , (Vo...rench Ambassador for International Investment, and..., , , ,What: Ambassador Appia is available to mee...tives adopted by France to further develop the fin...on and development., , ,When: Available for Interv...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3French Ambassador for International Investment to Visit Toronto December 11 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
...KJAVIK, Iceland, April 24 deCODE genetics,Inc. (N... its first quarter,2008 financial results in a pre...he close of the market in New York. The company wi...iscuss these results and recent,operating highligh...MT/1pm,British Summer Time., The webcast can be a...
... YORK, April 24 The Children,s Hospital Foundatio... Philadelphia(R), and,Royalty Pharma announced tod...lty interest in respect of sales of RotaTeq(R) fro... $182 million in cash., (Logo: http://www.newsco...addition of this royalty on RotaTeq(R), we further...
... provides 510(k) on examination gloves made from U...e for people with Type I latex allergy, MARICOPA,...t produces natural rubber found to be safe for med....S. Food and Drug Administration (FDA) to market,t...t crop native to the,U.S. Southwest. The examinati...
Other Biology Technology:deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results 2Royalty Pharma Acquires Royalty Interest in RotaTeq(R) from The Children's Hospital Foundation for $182 Million 2Royalty Pharma Acquires Royalty Interest in RotaTeq(R) from The Children's Hospital Foundation for $182 Million 3FDA Clears First Medical Product Made From Yulex(R) Natural Rubber 2
(Date:11/24/2009)... opening new doors to understanding how sounds ass...f a marine mammal or if they hear it at all. , ...ners that NASA uses to detect flaws in the space s...ng scientists to peek inside the giant head of a w...sional replicas of a whale,s hearing anatomy using...
(Date:11/24/2009)...EW YORK (November 24, 2009) -- The Wildlife Conser...aling that the last remaining population of Siberi... the rising tide of poaching and habitat loss. , ...Russian officials of what needs to be done to prot...at. , The report was released by th...
(Date:11/23/2009)...earch presents strong evidence that the "synergist...traffic-related pollution and indoor endotoxin cau...other exposure alone. , Environmental health s...lege of Medicine have shown that children exposed ...nd indoor endotoxin during early life are six time...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Many Teens Circumvent Tanning Bed Laws 57851 1Many Teens Circumvent Tanning Bed Laws 57851 2Many Teens Circumvent Tanning Bed Laws 57851 3The doctor can understand you now 57848 1The doctor can understand you now 57848 2The doctor can understand you now 57848 3Drug eluting stents safe effective for treatment of chronic total occlusions 57845 1Drug eluting stents safe effective for treatment of chronic total occlusions 57845 2
...me Research Institute (NHGRI), part of the Nationa...e of the first version of a free online toolkit ai...ects, physical characteristics and environmental e...er to compare data from multiple studies, accelera... environmental factors that cause cancer, heart di...
... exposed to Agent Orange are at increased risk of ...ers report. , A study of 1,495 veterans who under...us prostates showed that the 206 exposed to Agent ...heir cancer recurring despite the fact that their ... of surgery. And, their cancer came back with a ve...
...ican Chemical Society (ACS) Weekly PressPac from t... 34 peer-reviewed journals and Chemical & Enginee...or the American Chemical Society as the source for...ortal.acs.org/portal/PublicWebSite/pressroom/press...SE , First broad spectrum anti-microbial paint t...
Other Biology News: Free online toolkit provides standard measures for genome and population studies 2 Free online toolkit provides standard measures for genome and population studies 3Agent Orange exposure increases veterans' risk of aggressive recurrence of prostate cancer 2Agent Orange exposure increases veterans' risk of aggressive recurrence of prostate cancer 3American Chemical Society Weekly PressPac -- April 15, 2009 2American Chemical Society Weekly PressPac -- April 15, 2009 3American Chemical Society Weekly PressPac -- April 15, 2009 4American Chemical Society Weekly PressPac -- April 15, 2009 5American Chemical Society Weekly PressPac -- April 15, 2009 6
Mouse Anti-Human LDB3 Monoclonal Antibody, Unconjugated, Clone 3C8 from Abnova Corporation
Mouse Anti-Human NCLN Polyclonal Antibody, Unconjugated from Abnova Corporation
5' RACE Abridged Anchor Primer from Invitrogen
His-Patch ThioFusion Expression System from Invitrogen
Biology Products: